Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers, Ro and LifeMD to sell Wegovy, as it looks to stem sales of copies of its popular weight-loss drug and expand access to cash-paying patients.

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.

Novo Nordisk collaborates with telehealth companies to expand sales and access to its weight-loss drug Wegovy, amidst efforts to curb copies. Partnering with Hims & Hers, Ro, and LifeMD, the firm aims to widen access for cash-paying patients by offering reduced prices and promoting availability despite legal challenges.